Drug Profile
Moexipril
Alternative Names: Cardiotensin; CI 925; Femipres; Fempress; Perdix; Primoxil; RS 10029; RS 10085; Tensotec; UnivascLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antihypertensives; Tetrahydroisoquinolines
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 31 Oct 2012 Actavis has been acquired and merged into Watson Pharmaceuticals
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals